Low molecular weight heparin or semuloparin should not be recommended for thromboprophylaxis in ambulatory solid cancer patients undergoing chemotherapy

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)821-822
Number of pages2
JournalThrombosis Research
Volume130
Issue number5
DOIs
StatePublished - Nov 2012

ASJC Scopus subject areas

  • Hematology

Cite this